Vaxcyte Inc. (5VA)
XETR
67.00
+17.20 (+34.54%)
Real-time Data
07:00 AM
Day's Range
54.5076.50
52 wk Range
40.6076.50
Overview - 5VA - Vaxcyte Inc.
Key Statistics
Trading
Volume
171
Average Volume
22
Peers - 5VA - Vaxcyte Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
- 5VAXETRVaxcyte Inc.+18.06%52-week change—P/E (Trailing)—Profit Margin
- ANLXETRAnalog Devices, Inc.+39.03%52-week change45.97P/E (Trailing)‪29.78%‬Profit Margin
- 0QFXETRModerna Inc.+87.29%52-week change-22.43P/E (Trailing)‪-141.42%‬Profit Margin
- BBZAXETRBB Biotech AG+42.63%52-week change13.32P/E (Trailing)‪127.31%‬Profit Margin
- 7V0XETRDarwin AG+15.00%52-week change140.00P/E (Trailing)‪1.00%‬Profit Margin
- 1AEXETRargenx SE+27.49%52-week change—P/E (Trailing)‪32.26%‬Profit Margin
- A1P0XETRDefiance AI & Power Infrastructure ETF+12.48%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 5VA - Vaxcyte Inc.
About
Vaxcyte Inc. is a clinical-stage vaccine company focused on developing next-generation vaccines for bacterial infectious diseases. The company uses its proprietary cell-free protein synthesis platform to design and produce optimized protein carriers and antigens, supporting the creation of conjugate and protein-based…
SectorHealthcare
IndustryBiotechnology
Employees507
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
